This week, host Brian Mac Mahon speaks with Nishit Pancholi, Co-founder, COO, and CMO of Jointechlabs.

In this episode, Brian and Nishit talk about how Jointechlabs started, their struggles, and how they overcame them. The mind-blowing technology they have for regenerative medicine explains why you should invest in them.

About Jointechlabs:

Jointechlabs (JTL) is an emerging worldwide leader in point-of-care regenerative medicine therapies.

MiniTC™ - FDA cleared 

Mini-Stem System™ - For EU and ROW

With their devices and technology, they enable healthcare practitioners (HCPs), and hospitals to provide safe, cost-effective non-surgical regenerative medicine therapies at the point of care without change in the infrastructure. Both MiniTC™ and Mini-Stem System™ are medical devices that can be used as stand-alone or as a platform for the development of clinical therapies and 3D Bioprinting of tissues.

For more info, please visit www.jointechlabs.com

If you have the next big idea, apply to the Expert Dojo Accelerator:

www.expertdojo.com